PHARMA EVIDENCE ApS — Credit Rating and Financial Key Figures

PHARMA EVIDENCE ApS (CVR number: 34586519) is a company from FURESØ. The company recorded a gross profit of -157.7 kDKK in 2024. The operating profit was -185 kDKK, while net earnings were -179.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was -33.8 %, which can be considered poor and Return on Equity (ROE) was -110.9 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 34.1 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. PHARMA EVIDENCE ApS's liquidity measured by quick ratio was 1.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.